buprenorphine hydrochlorie
buprenorphine hydrochlorie structure
|
Common Name | buprenorphine hydrochlorie | ||
|---|---|---|---|---|
| CAS Number | 53152-21-9 | Molecular Weight | 504.10100 | |
| Density | 1.26g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C29H42ClNO4 | Melting Point | 260-262ºC (dec.) | |
| MSDS | Chinese USA | Flash Point | 51.8 °F | |
| Symbol |
GHS07, GHS08 |
Signal Word | Warning | |
|
Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
J. Anal. Toxicol. 37(3) , 159-65, (2013) A sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS-MS) method has been developed and validated for the quantification of buprenorphine, fentanyl and lysergic acid diethylamide (LSD) in whole blood. Sample preparation was per... |
|
|
Disaccharides in urine samples as markers of intravenous abuse of methadone and buprenorphine.
J. Anal. Toxicol. 37(9) , 652-8, (2013) Methadone and buprenorphine are commonly used as oral substitutes in opiate maintenance programs to treat persons who are dependent on heroin. During these programs, patients are not allowed to continue using illicit drugs. Abstinence can easily be monitored ... |
|
|
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Presse Med. 43(12 Pt 1) , 1314-6, (2014)
|
|
|
Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
J. Acquir. Immune Defic. Syndr. 67(5) , e142, (2014)
|
|
|
Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
J. Opioid Manag. 9(2) , 111-9, (2013) To develop effective programs for people who are opioid dependent and to impact the opioid epidemic in New York City, it is crucial to monitor attitudes about opioid addiction treatments among opioid users who have experienced barriers to engagement and reten... |
|
|
[Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice].
Therapie. 68(3) , 155-61, (2013) To describe opiate substitution treatment (OST) cycles in a five year followed-up cohort of patients initiating OST during 5 years in ambulatory practice.Data were extracted from Health Insurance System Database from January 1(st) 2005 to December 31(st) 2010... |
|
|
Confronting the stigma of opioid use disorder--and its treatment.
JAMA 311(14) , 1393-4, (2014)
|
|
|
Access to treatment for opioid dependence in rural America: challenges and future directions.
JAMA Psychiatry 71(4) , 359-60, (2014)
|
|
|
Efforts to reduce overdose deaths.
Am. J. Public Health 103(8) , e1-2, (2013)
|
|
|
Schwartz et al. respond.
Am. J. Public Health 103(8) , e2-3, (2013)
|